3-(2,5-DIFLUOROPHENYL)-6-(1-ETHYL-1H-INDOL-5-YL)-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINE
UNII 6V2M211JU6
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-(2,5-difluorophenyl)-6-(1-ethyl-1h-indol-5-yl)-1,2,4-triazolo(4,3-b)pyridazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6V2M211JU6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1243273-19-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H15F2N5 IEMAECIFHOYZSP-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-(2,5-difluorophenyl)-6-(1-ethyl-1h-indol-5-yl)-1,2,4-triazolo(4,3-b)pyridazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.